INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $55 | -99.7% | 35 | -99.6% | 0.00% | – |
| Q3 2022 | $16,000 | -11.1% | 9,335 | -11.1% | 0.00% | – |
| Q2 2022 | $18,000 | -45.5% | 10,499 | +12.9% | 0.00% | – |
| Q1 2022 | $33,000 | -29.8% | 9,300 | -2.1% | 0.00% | – |
| Q4 2021 | $47,000 | -29.9% | 9,500 | +2.2% | 0.00% | – |
| Q3 2021 | $67,000 | -22.1% | 9,300 | 0.0% | 0.00% | – |
| Q2 2021 | $86,000 | 0.0% | 9,300 | 0.0% | 0.00% | – |
| Q1 2021 | $86,000 | +4.9% | 9,300 | 0.0% | 0.00% | – |
| Q4 2020 | $82,000 | -24.1% | 9,300 | 0.0% | 0.00% | – |
| Q3 2020 | $108,000 | -61.2% | 9,300 | -9.7% | 0.00% | -100.0% |
| Q2 2020 | $278,000 | +265.8% | 10,300 | +0.5% | 0.00% | – |
| Q1 2020 | $76,000 | +145.2% | 10,250 | +10.2% | 0.00% | – |
| Q4 2019 | $31,000 | +63.2% | 9,300 | 0.0% | 0.00% | – |
| Q3 2019 | $19,000 | -29.6% | 9,300 | 0.0% | 0.00% | – |
| Q2 2019 | $27,000 | -22.9% | 9,300 | 0.0% | 0.00% | – |
| Q1 2019 | $35,000 | -5.4% | 9,300 | 0.0% | 0.00% | – |
| Q4 2018 | $37,000 | -28.8% | 9,300 | 0.0% | 0.00% | – |
| Q3 2018 | $52,000 | -38.8% | 9,300 | -57.3% | 0.00% | – |
| Q2 2018 | $85,000 | -17.5% | 21,800 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $103,000 | +14.4% | 21,800 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $90,000 | -34.8% | 21,800 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $138,000 | -19.3% | 21,800 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $171,000 | – | 21,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |